Journal of Ocular Pharmacology and Therapeutics · 1996 · 41 citations · 23 references
PharmacyOphthalmologyPharmaceuticsOcular Drug DeliveryOcular PharmacologyOphthalmic Drug DeliveryInsulin TherapyOcular BioavailabilityOcular Penetration EnhancementOphthalmic FormulationsOphthalmic SolutionsVeterinary Ocular PharmacologyBlinking DynamicsBlinking ResponseCanine Diabetes MellitusChemical Permeation EnhancersDrug-induced Ocular IrritationGlucose-stimulated Insulin SecretionOcular Permeation EnhancersOphthalmic Drug Safety
Regular porcine insulin was administered as eye drops to eight healthy, euglycemic dogs. Insulin was applied alone and in combination with six different permeation enhancers. Serum glucose and insulin were monitored for four hours following the eye drops. Significant changes in serum glucose and/or insulin occurred when the insulin was administered with 0.5% saponin, 0.5% and 1% BL-9, 0.5% and 1% dodecylmaltoside, and 0.5% and 1% tetradecylmaltoside. Insulin delivered alone and in the presence of 0.5% Brij-78 and 0.5% fusidic acid did not significantly alter glucose and/or insulin concentrations. Solutions containing 0.5% saponin induced signs of ocular irritation for approximately 5 minutes. Transient blinking (1-5 mins.) was encountered with solutions containing 1% BL-9, 1% dodecylmaltoside, and 1% tetradecylmaltoside. No ocular signs occurred with the administration of insulin alone or with 0.5% solutions of Brij-78, fusidic acid, BL-9, dodecylmaltoside, and tetradecylmaltoside. This study demonstrated that short-acting insulin is systemically absorbed in dogs via the ocular route when applied with certain emulsants.
23
Intranasal Aerosolized Insulin
Robert T. Salzman, JoAnn E. Manson, George T. Griffing et al. · New England Journal of Medicine · 1985 · 186 citations
Nasal Absorption of Insulin in Dogs
Shinichiro Hirai, Toshiaki Ikenaga, Tai Matsuzawa · Diabetes · 1978 · 132 citations